Literature DB >> 15004215

Isolation and characterization of a new major intestinal CYP3A form, CYP3A62, in the rat.

T Matsubara1, H J Kim, M Miyata, M Shimada, K Nagata, Y Yamazoe.   

Abstract

Based on information of the nucleotide sequence obtained from rat genome clones, a new CYP3A (CYP3A62) cDNA was isolated from the cDNA library of a rat liver. The CYP3A62 cDNA was 1746 base pairs (bp) in length, which included 1491 bp of an open reading frame and 93 bp and 209 bp of the respective 5'- and 3'-noncoding regions. Amino acid sequence deduced from CYP3A62 cDNA shared the highest similarity with rat CYP3A9 (79.9%) among human and rat CYP3A forms previously reported. CYP3A62 mRNA and protein were consistently detected in small intestines as well as livers. CYP3A62 was a major form in small intestines of both sexes but was a female-predominant form in livers of adult rats. CYP3A62 in both tissues of male and female rats were clearly enhanced by the treatment with dexamethasone. These expression profiles resembled those of CYP3A9. Despite clear detection of CYP3A62, no detectable levels of CYP3A1 and CYP3A2 proteins, as well as those of mRNAs, were found in the intestinal tract. Therefore, CYP3A62 may play major roles together with CYP3A9 and CYP3A18 in endogenous or exogenous detoxification at the absorption site.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004215     DOI: 10.1124/jpet.103.061671

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

Review 1.  Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.

Authors:  K Sandy Pang; Michael Weiss; Panos Macheras
Journal:  AAPS J       Date:  2007-06-29       Impact factor: 4.009

Review 2.  Use of in vivo animal models to assess pharmacokinetic drug-drug interactions.

Authors:  Cuyue Tang; Thomayant Prueksaritanont
Journal:  Pharm Res       Date:  2010-04-29       Impact factor: 4.200

3.  Isocaloric high-fat feeding directs hepatic metabolism to handling of nutrient imbalance promoting liver fat deposition.

Authors:  R Díaz-Rúa; E M van Schothorst; J Keijer; A Palou; P Oliver
Journal:  Int J Obes (Lond)       Date:  2016-03-22       Impact factor: 5.095

4.  Inhibition of CYP3A-mediated Midazolam Metabolism by Kaempferia Parviflora.

Authors:  Yumika Kashiwabuchi; Yuki Nishimura; Norimitsu Kurata; Mariko Iwase; Yuji Kiuchi; Koji Nobe
Journal:  Food Saf (Tokyo)       Date:  2022-03-03

5.  Pharmacokinetics of mirtazapine and its main metabolites after single intravenous and oral administrations in rats at two dose rates.

Authors:  Mohammad-Reza Rouini; Hoda Lavasani; Behjat Sheikholeslami; Helen Owen; Mario Giorgi
Journal:  Daru       Date:  2014-01-07       Impact factor: 3.117

Review 6.  An update on the role of intestinal cytochrome P450 enzymes in drug disposition.

Authors:  Fang Xie; Xinxin Ding; Qing-Yu Zhang
Journal:  Acta Pharm Sin B       Date:  2016-08-04       Impact factor: 11.413

7.  CRISPR knockout rat cytochrome P450 3A1/2 model for advancing drug metabolism and pharmacokinetics research.

Authors:  Jian Lu; Yanjiao Shao; Xuan Qin; Daozhi Liu; Ang Chen; Dali Li; Mingyao Liu; Xin Wang
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

8.  Triptolide Induces hepatotoxicity via inhibition of CYP450s in Rat liver microsomes.

Authors:  Yan Lu; Tong Xie; Yajie Zhang; Fuqiong Zhou; Jie Ruan; Weina Zhu; Huaxu Zhu; Zhe Feng; Xueping Zhou
Journal:  BMC Complement Altern Med       Date:  2017-01-05       Impact factor: 3.659

9.  Humanized UGT2 and CYP3A transchromosomic rats for improved prediction of human drug metabolism.

Authors:  Yasuhiro Kazuki; Kaoru Kobayashi; Masumi Hirabayashi; Satoshi Abe; Naoyo Kajitani; Kanako Kazuki; Shoko Takehara; Masato Takiguchi; Daisuke Satoh; Jiro Kuze; Tetsushi Sakuma; Takehito Kaneko; Tomoji Mashimo; Minori Osamura; Mari Hashimoto; Riko Wakatsuki; Rika Hirashima; Ryoichi Fujiwara; Tsuneo Deguchi; Atsushi Kurihara; Yasuko Tsukazaki; Naoto Senda; Takashi Yamamoto; Nico Scheer; Mitsuo Oshimura
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-04       Impact factor: 11.205

Review 10.  Sucralose, a synthetic organochlorine sweetener: overview of biological issues.

Authors:  Susan S Schiffman; Kristina I Rother
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2013       Impact factor: 6.393

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.